David Kirske, EVP, Chief Financial Officer at CTI BIOPHARMA CORP (CTIC), sold 45,184 shares at $6.02 ($272K) on 2022-09-16, disclosed to the SEC on 2022-09-20.
Open-market sale of $272k CTIC by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.02 | 22,592 | $136K | 50.0% |
| 2 | $6.02 | 22,592 | $136K | 50.0% |
| Total | $6.02 avg | 45,184 | $272K | 100% |
| Filing → |
| CTIC | SELL | 2023-01-03 | $487K | — | Filing → |
| CTIC | SELL | 2022-10-06 | $13K | — | Filing → |
| CTIC | SELL | 2022-10-03 | $1.7M | — | Filing → |